{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:38:29Z","timestamp":1793090309611,"version":"4.5.0"},"reference-count":104,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003851","name":"Heilongjiang Province Department of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003851","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005891","name":"National Administration of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005891","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005046","name":"Heilongjiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["PL2025H255"],"award-info":[{"award-number":["PL2025H255"]}],"id":[{"id":"10.13039\/501100005046","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374286"],"award-info":[{"award-number":["82374286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.critrevonc.2026.105542","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:59:03Z","timestamp":1786723143000},"page":"105542","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The biphasic role of reactive oxygen species in ovarian cancer progression and therapeutics: Crosstalk among metabolism, ferroptosis, and the tumor immune microenvironment"],"prefix":"10.1016","volume":"227","author":[{"given":"Yixin","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8517-7603","authenticated-orcid":false,"given":"Yuehui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105542_bib1","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.3390\/cancers15215136","article-title":"Auranofin induces lethality driven by reactive oxygen species in high-grade serous ovarian cancer cells","volume":"15","author":"Abdalbari","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105542_bib2","doi-asserted-by":"crossref","first-page":"B061","DOI":"10.1158\/2326-6074.IO2025-B061","article-title":"Abstract B061: Sialylation-driven MDSC generation shapes the ovarian tumor immune microenvironment","volume":"13","author":"Alvero","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105542_bib3","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1039\/D4BM01683A","article-title":"Self-targeted nanosystem for enhanced chemodynamic cancer therapy","volume":"13","author":"Asif","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib4","first-page":"1502","article-title":"NRF2 induces cisplatin resistance through activation of autophagy in ovarian carcinoma","volume":"7","author":"Bao","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib5","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mc.22615","article-title":"ABCF2, an NRF2 target gene, contributes to cisplatin resistance in ovarian cancer cells","volume":"56","author":"Bao","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.critrevonc.2026.105542_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1532097","article-title":"Expulsion of iron-rich ferritin via CD63-mediated exosome drives ferroptosis resistance in ovarian cancer cells","volume":"13","author":"Battaglia","year":"2025","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2023.1272667","article-title":"Iron affects the sphere-forming ability of ovarian cancer cells in non-adherent culture conditions","volume":"11","author":"Battaglia","year":"2023","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib8","first-page":"1007","article-title":"Ovarian cancer and its management through advanced drug delivery system","author":"Bose","year":"2025","journal-title":"Med. Oncol."},{"issue":"3390","key":"10.1016\/j.critrevonc.2026.105542_bib9","article-title":"Redox Regulation of STAT1 and STAT3 signaling","volume":"21","author":"Butturini","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","article-title":"Lactate and lactylation in cancer","volume":"10","author":"Chen","year":"2025","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105542_bib11","first-page":"2623","article-title":"Atrazine promoted epithelial ovarian cancer cells proliferation and metastasis by inducing low dose reactive oxygen species (ROS)","volume":"19","author":"Chen","year":"2021","journal-title":"Iran. J. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib12","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/antiox13060735","article-title":"Active DNA Demethylase, TET1, increases oxidative phosphorylation and sensitizes ovarian cancer stem cells to mitochondrial complex I Inhibitor","volume":"13","author":"Chen","year":"2024","journal-title":"Antioxidants"},{"key":"10.1016\/j.critrevonc.2026.105542_bib13","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/antiox10121883","article-title":"Pardaxin activates excessive mitophagy and mitochondria-mediated apoptosis in human ovarian cancer by inducing reactive oxygen species","volume":"10","author":"Chen","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.critrevonc.2026.105542_bib14","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1248\/bpb.b23-00349","article-title":"Oxfendazole induces apoptosis in ovarian cancer cells by activating JNK\/MAPK pathway and inducing reactive oxygen species generation","volume":"46","author":"Chen","year":"2023","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.critrevonc.2026.105542_bib15","article-title":"Ovulation releases G-CSF to induce peritoneal neutrophil influx and netosis, facilitating peritoneal seeding of high-grade serous carcinoma","volume":"70","author":"Chu","year":"2025","journal-title":"Neoplasia N. Y. N. Y"},{"key":"10.1016\/j.critrevonc.2026.105542_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115696","article-title":"Sonodynamic therapy: transforming sound into light for hard-to-treat tumours","volume":"226","author":"Cressey","year":"2025","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"10.1016\/j.critrevonc.2026.105542_bib17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/antiox11081544","article-title":"Decreased levels of GSH are associated with platinum resistance in high-grade serous ovarian cancer","volume":"11","author":"Criscuolo","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.critrevonc.2026.105542_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114477","article-title":"Biomarkers of oxidative stress and antioxidant defense","volume":"209","author":"Demirci-\u00c7eki\u00e7","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.critrevonc.2026.105542_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1186\/s40001-024-02050-9","article-title":"TCEB2\/HIF1A signaling axis promotes chemoresistance in ovarian cancer cells by enhancing glycolysis and angiogenesis","volume":"29","author":"Deng","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.critrevonc.2026.105542_bib20","doi-asserted-by":"crossref","first-page":"4298","DOI":"10.1158\/1538-7445.AM2025-4298","article-title":"Investigating the potential of EO3001 as a therapeutic agent for clear cell ovarian cancers harboring ARID1A mutations","volume":"85","author":"Ding","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105542_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s13273-023-00379-6","article-title":"The cytotoxic and antitumoral effects of Remdesivir, an antiviral RdRp inhibitor, on different cancer cells in vitro","volume":"20","author":"Eryilmaz","year":"2024","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib22","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3923\/ijp.2022.1199.1209","article-title":"Ginsenoside Rk1 Induced Apoptosis in Ovarian Cancer SK-OV-3 Cells via ROS-Mediated Caspase Signaling Pathway","volume":"18","author":"Fan","year":"2022","journal-title":"Int. J. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib23","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/ijms25010587","article-title":"Role of SLC7A11\/xCT in Ovarian Cancer","volume":"25","author":"Fantone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202006892","article-title":"Nanocatalytic theranostics with glutathione depletion and enhanced reactive oxygen species generation for efficient cancer therapy","volume":"33","author":"Fu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.critrevonc.2026.105542_bib25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s10330-022-0596-6","article-title":"A novel derivative of Genistein inhibits proliferation of ovarian cancer HO-8910 cells by regulating reactive oxygen species","volume":"8","author":"Gao","year":"2022","journal-title":"Oncol. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib26","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3892\/ijo.2024.5619","article-title":"Advances in the role of GPX3 in ovarian cancer (Review","volume":"64","author":"Geng","year":"2024","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib27","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.2174\/0929867331666230719142202","article-title":"Does each component of reactive oxygen species have a dual role in the tumor microenvironment?","volume":"31","author":"Hao","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105542_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.101928","article-title":"PARP inhibition promotes ferroptosis via repressing SLC7A11 and synergizes with ferroptosis inducers in BRCA-proficient ovarian cancer","volume":"42","author":"Hong","year":"2021","journal-title":"Redox Biol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib29","article-title":"High-valence selenium nanotherapeutics downregulates MUC16 to drive precise ovarian cancer therapy through redox perturbation","volume":"35","author":"Hu","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.critrevonc.2026.105542_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41419-026-08429-2","article-title":"The long noncoding RNA AC093895.1 promotes ovarian cancer formation and metastasis through a positive feedback network dependent on the transcription factor SOX4","volume":"17","author":"Huang","year":"2026","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105542_bib31","doi-asserted-by":"crossref","first-page":"5543","DOI":"10.7150\/jca.54699","article-title":"Dual role of reactive oxygen species and their application in cancer therapy","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105542_bib32","article-title":"Multiomic analysis identifies CPT1A as a potential therapeutic target in platinum-refractory, high-grade serous ovarian cancer","volume":"2","author":"Huang","year":"2021","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1186\/s12967-025-06640-x","article-title":"The interplay between driver mutation and oxidative stress in colorectal cancer: from pathogenesis to therapeutics","volume":"23","author":"Huang","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.snb.2025.138526","article-title":"A radical near-infrared fluorescent probe for imaging mitochondrial labile iron pool and evaluating ferroptosis inducers in ovarian cancer","author":"Huang","year":"2025","journal-title":"Sens. Actuators B Chem."},{"key":"10.1016\/j.critrevonc.2026.105542_bib35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105542_bib36","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1038\/s41401-024-01336-2","article-title":"The regulation and function of NRF2 signaling in ferroptosis-activated cancer therapy","volume":"45","author":"Jiang","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.critrevonc.2026.105542_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.canlet.2007.03.005","article-title":"Curcumin for chemoprevention of colon cancer","volume":"255","author":"Johnson","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105542_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/biom15010012","article-title":"Etoricoxib-NLC mitigates radiation-induced ovarian damage in rats: insights into pro-inflammatory cytokines, antioxidant activity, and hormonal responses","volume":"15","author":"Khateeb","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.critrevonc.2026.105542_bib39","doi-asserted-by":"crossref","first-page":"734","DOI":"10.4103\/RPS.RPS_25_25","article-title":"Apoptotic effect of linifanib on human ovarian cancer OVCAR3 cell line","volume":"20","author":"Lee","year":"2025","journal-title":"Res. Pharm. Sci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202403944","article-title":"Ovarian function restoration with biomimetic scaffold incorporating angiogenic molecules and antioxidant in chemotherapy-induced perimenopausal model","volume":"14","author":"Kim","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.critrevonc.2026.105542_bib41","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3892\/ol.2022.13200","article-title":"Revisiting therapeutic strategies for ovarian cancer by focusing on redox homeostasis","volume":"23","author":"Kobayashi","year":"2022","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105542_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1129352","article-title":"Evaluation of mitochondrial biogenesis and ROS generation in high-grade serous ovarian cancer","volume":"13","author":"Koc","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib43","series-title":"Oxidative Stress","first-page":"619","article-title":"Reactive oxygen species and cancer","author":"Kong","year":"2020"},{"key":"10.1016\/j.critrevonc.2026.105542_bib44","doi-asserted-by":"crossref","DOI":"10.1177\/09603271221089257","article-title":"An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species","volume":"41","author":"Lee","year":"2022","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","article-title":"Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10","volume":"43","author":"Lee","year":"2025","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105542_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2022.104321","article-title":"Linifanib induces apoptosis in human ovarian cancer cells via activation of FOXO3 and reactive oxygen species","volume":"15","author":"Lee","year":"2022","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.critrevonc.2026.105542_bib47","article-title":"Ferroptosis in ovarian cancer: a novel therapeutic strategy","volume":"11","author":"Li","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217903","article-title":"Metabolic gatekeeper ACAD9 coordinates linoleic acid metabolism and redox homeostasis via mitochondrial complex I to drive ovarian cancer progression","volume":"630","author":"Li","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105542_bib49","first-page":"41","article-title":"Reactive oxygen species reprogram macrophages to suppress antitumor immune response through the exosomal miR-155-5p\/PD-L1 pathway","volume":"41","author":"Li","year":"2022","journal-title":"J. Exp. Clin. Cancer Res. CR"},{"key":"10.1016\/j.critrevonc.2026.105542_bib50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s13273-022-00322-1","article-title":"NRF2 suppresses erastin-induced ferroptosis through activating system Xc(-) in ovarian cancer","volume":"20","author":"Li","year":"2024","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib51","article-title":"Global epidemiology of ovarian cancer: patterns, trends, and risk factors","author":"Li","year":"2026","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102659","article-title":"Reactive oxygen species and ovarian diseases: antioxidant strategies","volume":"62","author":"Liang","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13048-024-01359-7","article-title":"From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer","volume":"17","author":"Liu","year":"2024","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.critrevonc.2026.105542_bib54","first-page":"2174","article-title":"Brusatol regulates ferroptosis of ovarian cancer through the NRF2\/HO-1\/NQO1 and AKT\/mTOR double signaling pathways","volume":"10","author":"Liu","year":"2025","journal-title":"Curr. Pharm. Des."},{"issue":"3390","key":"10.1016\/j.critrevonc.2026.105542_bib55","article-title":"Exploring strategies to prevent and treat ovarian cancer in terms of oxidative stress and antioxidants","volume":"14","author":"Long","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.critrevonc.2026.105542_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2006.10.029","article-title":"Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy","volume":"252","author":"L\u00f3pez-L\u00e1zaro","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105542_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122820","article-title":"Hypoxia-responsive micelles deprive cofactor of stearoyl-CoA desaturase-1 and sensitize ferroptotic ovarian cancer therapy","volume":"314","author":"Luo","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105542_bib58","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.24976\/Discov.Med.202537197.99","article-title":"S100A8 mediates autophagy and apoptosis in ovarian cancer cells via the PI3K\/Akt Pathway","volume":"37","author":"Ma","year":"2025","journal-title":"Discov. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib59","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbrc.2023.04.111","article-title":"Tripterygium glycosides reverse chemotherapy resistance in ovarian cancer by targeting the NRF2\/GPX4 signal axis to induce ferroptosis of drug-resistant human epithelial ovarian cancer cells","volume":"665","author":"Ma","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2026.105542_bib60","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3390\/futurepharmacol4030035","article-title":"Understanding the Impact of Oxidative Stress on Ovarian Cancer: Advances in Diagnosis and Treatment","volume":"4","author":"Meshkovska","year":"2024","journal-title":"Future Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2025.102225","article-title":"DIO3 depletion attenuates ovarian cancer growth via reduced glycolysis and alterations in glutamine metabolism","volume":"100","author":"Moskovich","year":"2025","journal-title":"Mol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105542_bib62","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1111\/cas.15068","article-title":"Reactive oxygen species in cancer: current findings and future directions","volume":"112","author":"Nakamura","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib63","series-title":"Study on mechanisms of artesunate induced ferroptosis in the ovarian cancer","author":"Nie","year":"2024"},{"key":"10.1016\/j.critrevonc.2026.105542_bib64","article-title":"Artesunate triggers ferroptosis in ovarian cancer via GP130-mediated IL-6\/STAT3\/OTUB1\/SLC711 axis disruption","volume":"148","author":"Nie","year":"2025","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.critrevonc.2026.105542_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121110","article-title":"Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy","volume":"277","author":"Niu","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.critrevonc.2026.105542_bib66","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.jhep.2025.04.034","article-title":"New platinum derivatives selectively cause double-strand DNA breaks and death in na\u00efve and cisplatin-resistant cholangiocarcinomas","volume":"83","author":"Olaizola","year":"2025","journal-title":"J. Hepatol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108691","article-title":"Design, synthesis, and biological evaluation of pyrazole-based combretastatin A-4 analogues as potential cytotoxic agents","volume":"163","author":"Omar","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.critrevonc.2026.105542_bib68","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202500065","article-title":"Nitidine and Paclitaxel-Coloaded Lipid-Chitosan Hybrid Nanoparticles Overcoming ABCB1-Mediated Multidrug Resistance in Ovarian Cancer","author":"Ozturk","year":"2025","journal-title":"ChemMedChem"},{"key":"10.1016\/j.critrevonc.2026.105542_bib69","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: the bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib70","doi-asserted-by":"crossref","DOI":"10.31083\/FBL39675","article-title":"Iron Fist in a Velvet Glove: Class IV Ferroptosis Inducers as a Novel Strategy to Target Ovarian Cancer","author":"Petriaggi","year":"2025","journal-title":"Front. Biosci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib71","doi-asserted-by":"crossref","DOI":"10.20517\/cdr.2024.111","article-title":"Ovarian tumor microenvironment contributes to tumor progression and chemoresistance","author":"Ponton-Almodovar","year":"2024","journal-title":"Cancer Drug. Resist."},{"key":"10.1016\/j.critrevonc.2026.105542_bib72","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm1320","article-title":"The antioxidant function of the p53 tumor suppressor","volume":"11","author":"Sablina","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib73","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/1871520621666210608095512","article-title":"Reactive Oxygen Species (ROS): Key Components in Cancer Therapies","volume":"22","author":"Sahoo","year":"2022","journal-title":"Anticancer. Agents Med. Chem."},{"key":"10.1016\/j.critrevonc.2026.105542_bib74","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1053\/j.seminoncol.2021.05.002","article-title":"Implications of reactive oxygen species on cancer formation and its treatment","volume":"48","author":"Shah","year":"2021","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib75","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41580-020-0230-3","article-title":"Reactive oxygen species (ROS) as pleiotropic physiological signalling agents","volume":"21","author":"Sies","year":"2020","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.178070","article-title":"Potential anti-ovarian cancer agent: Isoaaptamine interference epithelial-mesenchymal transition, induces intrinsic apoptosis, and suppresses angiogenesis","volume":"1005","author":"Su","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib77","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41419-022-04510-8","article-title":"Extracellular vesicles in ovarian cancer chemoresistance, metastasis, and immune evasion","volume":"13","author":"Tian","year":"2022","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105542_bib78","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.mito.2012.08.002","article-title":"Redox regulation of cancer cell migration and invasion","volume":"13","author":"Tochhawng","year":"2013","journal-title":"Mitochondrion"},{"key":"10.1016\/j.critrevonc.2026.105542_bib79","doi-asserted-by":"crossref","first-page":"663","DOI":"10.3390\/antiox11040663","article-title":"Role of NRF2 in Ovarian Cancer","volume":"11","author":"Tossetta","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.critrevonc.2026.105542_bib80","article-title":"Ovatodiolide triggers ferroptosis in high-grade serous ovarian cancer through HMOX1 upregulation","volume":"33","author":"Tzeng","year":"2025","journal-title":"Mol. Ther. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib81","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJMoa1708618","article-title":"Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer","volume":"378","author":"Van Driel","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2026.105542_bib82","doi-asserted-by":"crossref","unstructured":"Wang, M., Chang, M., Li, C., Chen, Q., Hou, Z., Xing, B., Lin, J., 2022. Tumor-Microenvironment-Activated Reactive Oxygen Species Amplifier for Enzymatic Cascade Cancer Starvation\/Chemodynamic \/Immunotherapy. https:\/\/doi.org\/10.1002\/adma.202106010.","DOI":"10.1002\/adma.202106010"},{"key":"10.1016\/j.critrevonc.2026.105542_bib83","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/antiox14121504","article-title":"Extracellular Vesicle-Mediated Delivery of Antioxidant Enzymes: Emerging Insights and Translational Opportunities","volume":"14","author":"Wang","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.critrevonc.2026.105542_bib84","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10565-025-10094-8","article-title":"ETV4 promotes ovarian cancer growth by regulating mitochondrial function through Mfn2 ubiquitination mediated by the E3 ubiquitin ligase MARCH9","volume":"41","author":"Wang","year":"2025","journal-title":"Cell. Biol. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib85","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/cas.15627","article-title":"Diallyl trisulfide alleviates chemotherapy sensitivity of ovarian cancer via the AMPK\/SIRT1\/PGC1\u03b1 pathway","volume":"114","author":"Wang","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib86","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/imm.13793","article-title":"Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy","volume":"173","author":"Wang","year":"2024","journal-title":"Immunology"},{"key":"10.1016\/j.critrevonc.2026.105542_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.bpobgyn.2016.08.006","article-title":"Epidemiology of epithelial ovarian cancer","volume":"41","author":"Webb","year":"2017","journal-title":"Best. Pract. & Res. Clin. Obstet. Gynaecol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib88","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/s41571-024-00881-3","article-title":"Global epidemiology of epithelial ovarian cancer","volume":"21","author":"Webb","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib89","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1186\/s40001-025-02846-3","article-title":"ROS-mediated cell death and phase separation in gynecological malignancies","volume":"30","author":"Wei","year":"2025","journal-title":"Eur. J. Med. Res."},{"issue":"297","key":"10.1016\/j.critrevonc.2026.105542_bib90","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cancergen.2025.07.009","article-title":"The mechanism of lncRNA SSTR5-AS1 promoting ferroptosis resistance and immune escape in ovarian cancer cells by recruiting STAT3 to regulate SLC7A11 expression","volume":"296","author":"Wei","year":"2025","journal-title":"Cancer Genet."},{"key":"10.1016\/j.critrevonc.2026.105542_bib91","article-title":"Targeting ferroptosis: a promising avenue for ovarian cancer treatment","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3390\/cells14030213","article-title":"Metformin Induces Apoptosis and ferroptosis of Ovarian Cancer Cells Under Energy Stress Conditions","volume":"14","author":"Wu","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105542_bib93","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.jcis.2024.11.221","article-title":"Ultrasound and glutathione dual-responsive biomimetic nanoplatform for ultrasound\/magnetic resonance imaging and sonodynamic therapy of ovarian cancer","volume":"682","author":"Xie","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.critrevonc.2026.105542_bib94","article-title":"The role of macrophage polarization in ovarian cancer: from molecular mechanism to therapeutic potentials","volume":"16","author":"Xu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib95","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105542_bib96","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3892\/or.2022.8293","article-title":"Molecular mechanisms of platinum-based chemotherapy resistance in ovarian cancer (Review","volume":"47","author":"Yang","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2026.105542_bib97","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13048-025-01650-1","article-title":"Icariside II induces ferroptosis through the down-regulation of SLC7A11 in ovarian cancer","volume":"18","author":"Yuan","year":"2025","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.critrevonc.2026.105542_bib98","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110958","article-title":"CRABP2 reduces the sensitivity of Olaparib in ovarian cancer by downregulating Caspase-8 and decreasing the production of reactive oxygen species","volume":"393","author":"Zeng","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.critrevonc.2026.105542_bib99","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.3390\/cancers14112637","article-title":"The role of cancer-associated fibroblasts in ovarian cancer","volume":"14","author":"Zhang","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2026.105542_bib100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/med.21734","article-title":"Small molecules regulating reactive oxygen species homeostasis for cancer therapy","volume":"41","author":"Zhang","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.critrevonc.2026.105542_bib101","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1021\/acsnano.4c12237","article-title":"Activating the cGAS-STING pathway by manganese-based nanoparticles combined with platinum-based nanoparticles for enhanced ovarian cancer immunotherapy","volume":"19","author":"Zhang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.critrevonc.2026.105542_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108413","article-title":"Metabolic dependencies and targets in ovarian cancer","volume":"245","author":"Zhang","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105542_bib103","first-page":"1007","article-title":"Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the NRF2 pathway","author":"Zhao","year":"2021","journal-title":"Med. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105542_bib104","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119126","article-title":"Chrysotoxine regulates ferroptosis and the PI3K\/AKT\/mTOR pathway to prevent cervical cancer","volume":"338","author":"Zhou","year":"2025","journal-title":"J. Ethnopharmacol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826004294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T07:57:06Z","timestamp":1793087826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826004294"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":104,"alternative-id":["S1040842826004294"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105542","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The biphasic role of reactive oxygen species in ovarian cancer progression and therapeutics: Crosstalk among metabolism, ferroptosis, and the tumor immune microenvironment","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105542","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105542"}}